In focus · trending topic

Radioimmunotherapy

92 stories · following the connections

Actinium Pharmaceuticals to Host Webinar on June 12th to Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-B

By Nasdaq OMXMay 31, 2017, 11:36 AM UTC

Actinium Pharmaceuticals Granted Orphan Designation from the European Medicines Agency for Actimab-A

By Nasdaq OMXMay 24, 2017, 1:26 PM UTC

Actinium Pharmaceuticals Granted Orphan Designation from the European Medicines Agency for Actimab-A

By Nasdaq OMXMay 24, 2017, 1:26 PM UTC

Actinium Pharmaceuticals Granted Orphan Designation from the European Medicines Agency for Actimab-A

By Nasdaq OMXMay 24, 2017, 1:26 PM UTC

Actinium Pharmaceuticals to Present Actimab-A Data at the 10th International Symposium on Targeted Alpha Therapy

By Nasdaq OMXMay 23, 2017, 11:32 AM UTC

Actinium Pharmaceuticals to Present Actimab-A Data at the 10th International Symposium on Targeted Alpha Therapy

By Nasdaq OMXMay 23, 2017, 11:32 AM UTC

Actinium Pharmaceuticals to Present Actimab-A Data at the 10th International Symposium on Targeted Alpha Therapy

By Nasdaq OMXMay 23, 2017, 11:32 AM UTC

Actinium Pharmaceuticals Announces Appointment of Hematology Expert Dr. Richard Stone of the Dana-Farber Cancer Institute to its Scientific Advisory Board

By Nasdaq OMXMay 17, 2017, 11:01 AM UTC